Clevecord (HPC, Cord Blood)

Clevecord (HPC, Cord Blood) is a therapy that uses allogeneic cord blood hematopoietic progenitor cells for transplantation procedures. It is used with a preparative regimen to help rebuild the hematopoietic and immune systems in patients with disorders of the hematopoietic system. These disorders may be inherited, acquired, or result from myeloablative treatments.The decision to use Clevecord is based on a risk-benefit assessment considering the patient’s specific disease, stage, risk factors, disease manifestations, graft characteristics, and other available treatments or types of hematopoietic progenitor cells.

Recommended Dosage: The minimum recommended dosage of Clevecord (HPC, Cord Blood) is 2.5 x 10^7 nucleated cells/kg of body weight at the time of cryopreservation. Clevecord is intended for intravenous use only, and multiple units may be required to achieve the necessary dose. It is crucial to match at least 4 out of 6 HLA markers, specifically including HLA-A antigens, HLA-B antigens, and HLA-DRB1 alleles. Each unit’s HLA typing and nucleated cell count are provided on the container label or in the accompanying documentation.

• Patients receiving Clevecord may experience hypersensitivity reactions, including allergic responses. Symptoms can range from mild skin rashes to severe anaphylaxis, which requires immediate medical attention. Patients with a history of allergies should inform their healthcare provider before starting treatment.
  
• Infusion reactions are common and can occur during or shortly after the administration of Clevecord. Symptoms may include fever, chills, shortness of breath, and skin flushing. To minimize risk, healthcare providers should monitor patients closely during the infusion and have emergency medications available.
  
• Graft-versus-host disease (GVHD) is a serious condition that may occur, where the transplanted cells attack the recipient’s body. Symptoms include skin rash, liver dysfunction, and gastrointestinal issues. Prophylactic measures and immunosuppressive therapy are typically administered to reduce the risk of GVHD.
  
• Engraftment syndrome may occur as the transplanted cells begin to grow and produce new blood cells. Symptoms include fever, rash, and fluid retention. Early detection and treatment with corticosteroids can help manage this condition effectively.
  
• Graft failure occurs when the transplanted cells do not grow or function properly. It can lead to severe complications, such as infections or anemia. Regular monitoring and supportive care are essential to detect and address graft failure promptly.
  
• In rare cases, the transplanted stem cells may contain malignant cells, leading to cancer development in the recipient. Regular follow-up and monitoring are necessary to detect any signs of malignancy early on.
  
• Clevecord may carry the risk of transmitting infections from the donor to the recipient. Despite rigorous screening and testing, there remains a potential for transmission of viruses or bacteria. Patients should be informed about this risk and monitored for any signs of infection.
  
• There is a small risk that Clevecord may transmit rare genetic diseases present in the donor’s blood. Genetic counseling and thorough donor screening can help mitigate this risk, but it cannot be completely eliminated.
  

What documents are required to import CLEVECORD to India?

CLEVECORD (HPC, Cord Blood) can be imported by patients or government hospitals only in the patients’ name. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
  
• Patients diagnostic reports
  
• Patient ID proof (issued by the government of India)

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
  
• Import permit if applicable

CLEVECORD (HPC, Cord Blood) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Clevecord (HPC, Cord Blood) in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
  
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
  
• Medicine Price.
  
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
  
• Ensuring 100% transparency.

IPN (Indian Pharma Network) can facilitate the supply of CLEVECORD (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Clevecord (HPC, Cord Blood) price in India. 

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source the CLEVECORD (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Clevecord®?

Hematopoietic Progenitor Cell, Cord Blood is a Generic Name for the trade name drug Clevecord®.

What is the Manufacturer’s Name of Clevecord®?

Clevecord® is manufactured by Cleveland Cord Blood Center.

Is Clevecord® approved by the FDA?

Yes, Clevecord® is approved by the FDA. Date of first approval: September 12, 2016.

What is the dosage and form of Clevecord® supplied?

Clevecord® is supplied as a cryopreserved cell suspension in a sealed bag containing a minimum of 5 x 108 total nucleated cells with a minimum of 1.25 x 106 viable CD34+ cells in a volume of 25 milliliters for intravenous (IV) use. 

What are the most common side effects of Clevecord® (HPC, Cord Blood)? 

The most common infusion-related side effects of Clevecord® are fever, hypertension, vomiting, nausea, and bradycardia. 

How much does Clevecord® (HPC, Cord Blood) cost in India?

Prices may fluctuate over time due to market dynamics and regulatory changes. To obtain accurate and up-to-date information on the cost of Clevecord (HPC, Cord Blood) in India, it is recommended that you Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Clevecord® (HPC, Cord Blood) be available in SAARC countries? 

Apart from Gulf countries, Clevecord can be available in SAARC countries (India, Afghanistan, Bhutan, Bangladesh, Maldives, Nepal, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the supply of Clevecord in these countries, ensuring access to this therapeutic drug through legal and reliable channels.

What are the storage conditions of Clevecord® (HPC, Cord Blood)?

Store Clevecord® (HPC, Cord Blood) at or below -150 °C until ready for thawing and preparation.